•  
  •  
  •  
  •  

2025-12-23 14:31:29

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial

Keywords Selected:  BodalChemicals

Stock Report

  • India levies anti-dumping duty on imports of Trichloro Isocyanuric Acid from China PR and Japan
  • Bodal Chemicals Ltd conferred with prestigious National Energy Conservation Award
  • Bodal Chemicals Ltd starts commercial production at new manufacturing unit
  • Bodal Chemicals Ltd commences commercial production at new unit near Dahej
  • Bodal Chemicals Ltd Q2 FY2024 consolidated net profit declines to Rs. 1.24 crore
  • Bodal Chemicals Ltd posts consolidated PAT of Rs. 23.87 crores in Q1FY23
  • Bodal Chemicals Ltd Board recommends Final Dividend of Rs. 0.80
  • Bodal Chemicals Ltd consolidated Q4FY22 PAT up at Rs. 30.87 crores
  • Bodal Chemicals posts consolidated PAT of Rs. 24.32 crores in Q3 FY22
  • Bodal Chemicals Ltd consolidated Q2 FY2021-22 PAT drops QoQ to Rs. 25.22 crore

Latest Post

  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024